Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-13

Clinical Trial Update: Super-Rehab: Can we Achieve Coronary Artery Disease Regression? [NA]

View source ↗

Summary

The Super-Rehab study examining potential regression of coronary artery disease in metabolic syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Royal United Hospitals Bath NHS Foundation Trust | Conditions: Coronary Artery Disease, Metabolic Syndrome | NA | Status: COMPLETED